CIK 0001783032
ELEV Elevation Oncology, Inc.
Insider trading from SEC Form 4. Last filing Jul 24, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at Elevation Oncology, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 76 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | Timothy P Clackson director | UTender of shares Common Stockindirect: The Timothy P. Clackson Irrevocable GST Trust of 2020 | -47,330 | $0.36 | $17k | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Alan B. Sandler director | DDisposition to issuer Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | R Michael Carruthers director | DDisposition to issuer Stock Option (Right to Buy)derivative | -47,330 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Darcy Mootz director | DDisposition to issuer Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | UTender of shares Common Stock | -37,957 | $0.36 | $14k | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Steve Elms director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -31,238 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Julie M Cherrington director | DDisposition to issuer Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -79,327 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Alan B. Sandler director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Darcy Mootz director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Steve Elms director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -15,619 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Julie M Cherrington director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Timothy P Clackson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,619 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | R Michael Carruthers director | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,619 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Julie M Cherrington director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Alan B. Sandler director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Timothy P Clackson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -31,238 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Darcy Mootz director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -79,327 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | R Michael Carruthers director | DDisposition to issuer Stock Option (Right to Buy)derivative | -31,238 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Steve Elms director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -31,238 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Steve Elms director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | R Michael Carruthers director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Timothy P Clackson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Steve Elms director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: See footnote | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Timothy P Clackson director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -52,500 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | R Michael Carruthers director | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -28,800 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -53,433 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -225,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | DDisposition to issuer Stock Option (Right to Buy)derivative | -275,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jun 16, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +12,560 | - | - | 149,712 | Jun 18, 2025 |
| Jun 16, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -4,627 | $0.39 | $1,783 | 145,085 | Jun 18, 2025 |
| Jun 16, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitderivative | -12,560 | $0.00 | $0 | 0 | Jun 18, 2025 |
| Jun 5, 2025 | Julie M Cherrington director | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 9, 2025 |
| Jun 5, 2025 | Alan B. Sandler director | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 9, 2025 |
| Jun 5, 2025 | Darcy Mootz director | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 9, 2025 |
| Jun 5, 2025 | R Michael Carruthers director | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 9, 2025 |
| Jun 5, 2025 | Timothy P Clackson director | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 9, 2025 |
| Jun 5, 2025 | Steve Elms director | AGrant or award Stock Option (Right to Buy)derivativeindirect: See footnote | +35,000 | $0.00 | $0 | 35,000 | Jun 9, 2025 |
| May 15, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +6,250 | - | - | 139,455 | May 19, 2025 |
| May 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +2,643 | - | - | 10,859 | May 19, 2025 |
| May 15, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -2,303 | $0.30 | $690 | 137,152 | May 19, 2025 |
| May 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -784 | $0.30 | $235 | 10,075 | May 19, 2025 |
| May 15, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitderivative | -6,250 | $0.00 | $0 | 68,750 | May 19, 2025 |
| May 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitderivative | -2,343 | $0.00 | $0 | 25,782 | May 19, 2025 |
| May 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitderivative | -300 | $0.00 | $0 | 2,100 | May 19, 2025 |
| Mar 16, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +12,562 | - | - | 137,833 | Mar 18, 2025 |
| Mar 16, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -4,628 | $0.53 | $2,466 | 133,205 | Mar 18, 2025 |
| Mar 16, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitderivative | -12,562 | $0.00 | $0 | 12,560 | Mar 18, 2025 |
| Feb 15, 2025 | David Dornan CHIEF SCIENTIFIC OFFICER | MOption exercise Common Stock | +9,375 | - | - | 9,375 | Feb 19, 2025 |
| Feb 15, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +25,000 | - | - | 134,482 | Feb 19, 2025 |
| Feb 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +9,375 | - | - | 10,785 | Feb 19, 2025 |
| Feb 15, 2025 | Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER | MOption exercise Common Stock | +17,500 | - | - | 17,500 | Feb 19, 2025 |
| Feb 15, 2025 | David Dornan CHIEF SCIENTIFIC OFFICER | FTax withholding Common Stock | -4,152 | $0.67 | $2,789 | 5,223 | Feb 19, 2025 |
| Feb 15, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -9,211 | $0.67 | $6,187 | 125,271 | Feb 19, 2025 |
| Feb 15, 2025 | Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER | FTax withholding Common Stock | -5,189 | $0.67 | $3,485 | 12,311 | Feb 19, 2025 |
| Feb 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -2,780 | $0.67 | $1,867 | 8,005 | Feb 19, 2025 |
| Feb 15, 2025 | Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Feb 19, 2025 |
| Feb 15, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Feb 19, 2025 |
| Feb 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +300 | - | - | 8,305 | Feb 19, 2025 |
| Feb 15, 2025 | David Dornan CHIEF SCIENTIFIC OFFICER | MOption exercise Restricted Stock Unitderivative | -9,375 | $0.00 | $0 | 28,125 | Feb 19, 2025 |
| Feb 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -89 | $0.67 | $60 | 8,216 | Feb 19, 2025 |
| Feb 15, 2025 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitderivative | -25,000 | $0.00 | $0 | 75,000 | Feb 19, 2025 |
| Feb 15, 2024 | Valerie Malyvanh Jansen CHIEF MEDICAL OFFICER | MOption exercise Restricted Stock Unitderivative | -17,500 | $0.00 | $0 | 52,500 | Feb 19, 2025 |
| Feb 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Feb 19, 2025 |
| Feb 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitderivative | -9,375 | $0.00 | $0 | 28,125 | Feb 19, 2025 |
| Feb 15, 2025 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitderivative | -300 | $0.00 | $0 | 2,400 | Feb 19, 2025 |
| Dec 16, 2024 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +12,563 | - | - | 114,111 | Dec 18, 2024 |
| Dec 16, 2024 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -4,629 | $0.64 | $2,963 | 109,482 | Dec 18, 2024 |
| Dec 16, 2024 | Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitderivative | -12,563 | $0.00 | $0 | 25,122 | Dec 18, 2024 |
| Nov 15, 2024 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +300 | - | - | 1,508 | Nov 19, 2024 |
| Nov 15, 2024 | Tammy Furlong CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -98 | $0.53 | $52 | 1,410 | Nov 19, 2024 |
| Nov 15, 2024 | Tammy Furlong CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitderivative | -300 | $0.00 | $0 | 2,700 | Nov 19, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Timothy P Clacksondirector
- R Michael Carrutherscfo, officer, director
- Julie M Cherringtondirector
- David DornanCHIEF SCIENTIFIC OFFICER
- Steve Elmsdirector
- Joseph J Ferra JrCHIEF EXECUTIVE OFFICER
- Tammy FurlongCHIEF FINANCIAL OFFICER
- Valerie Malyvanh JansenCHIEF MEDICAL OFFICER
- Darcy Mootzdirector
- Alan B. Sandlerofficer, director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.